BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25071001)

  • 21. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country.
    Ige OM; Oladokun RE
    Indian J Tuberc; 2018 Oct; 65(4):322-328. PubMed ID: 30522620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who knows what: An exploration of the infant feeding message environment and intracultural differences in Port-au-Prince, Haiti.
    Fox EL; Pelto GH; Rasmussen KM; Debrosse MG; Rouzier VA; Pape JW; Pelletier DL
    Matern Child Nutr; 2018 Apr; 14(2):e12537. PubMed ID: 28976068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Haiti cardiovascular disease cohort: study protocol for a population-based longitudinal cohort.
    Lookens J; Tymejczyk O; Rouzier V; Smith C; Preval F; Joseph I; Baptiste RJ; Victor J; Severe P; Apollon S; Dumont E; Forestal G; St Preux S; Rivera V; Seo G; Charles B; Ariste W; Kingery J; Devieux J; Koenig S; Nash D; Fitzgerald D; Safford M; Deschamps MM; Pape J; McNairy M
    BMC Public Health; 2020 Nov; 20(1):1633. PubMed ID: 33131500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
    Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
    J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
    Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
    PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.
    Franke MF; Appleton SC; Bayona J; Arteaga F; Palacios E; Llaro K; Shin SS; Becerra MC; Murray MB; Mitnick CD
    Clin Infect Dis; 2008 Jun; 46(12):1844-51. PubMed ID: 18462099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
    Schackman BR; Neukermans CP; Fontain SN; Nolte C; Joseph P; Pape JW; Fitzgerald DW
    PLoS Med; 2007 May; 4(5):e183. PubMed ID: 17535105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
    Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis at an HIV testing center in Haiti.
    Joseph P; Severe P; Ferdinand S; Goh KS; Sola C; Haas DW; Johnson WD; Rastogi N; Pape JW; Fitzgerald DW
    AIDS; 2006 Feb; 20(3):415-8. PubMed ID: 16439875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth in late infancy among HIV-exposed children in urban Haiti is associated with participation in a clinic-based infant feeding support intervention.
    Heidkamp RA; Stoltzfus RJ; Fitzgerald DW; Pape JW
    J Nutr; 2012 Apr; 142(4):774-80. PubMed ID: 22378328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.
    Dharmadhikari AS; Mphahlele M; Venter K; Stoltz A; Mathebula R; Masotla T; van der Walt M; Pagano M; Jensen P; Nardell E
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1019-25. PubMed ID: 25189547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
    Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T
    PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.